SEC Form 4 · accession 0002064832-26-000266
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott T. Rottinghaus
Officer — Chief Medical Officer
Period of report
Aug 8, 2026
Accepted (ET)
Aug 10, 2026 · 9:00 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 8, 2026 | F | 1,467 | $13.34 | D | 23,787 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.